芯源微(688037.SH):中科天盛擬通過公開徵集轉讓的方式協議轉讓8.41%股份
格隆匯3月11日丨芯源微(688037.SH)公佈,持股5%以上股東瀋陽中科天盛自動化技術有限公司(簡稱“中科天盛”)持有公司股份16,899,750股,佔公司總股本的8.41%(簡稱“標的股份”),股份性質全部爲無限售條件流通股。中科天盛擬通過公開徵集轉讓的方式協議轉讓所持公司的全部股份,轉讓價格不低於人民幣85.71元/股,本次股份轉讓完成後,中科天盛將不再持有公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.